HALCINONIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for halcinonide and what is the scope of freedom to operate?
Halcinonide
is the generic ingredient in three branded drugs marketed by Chartwell Rx, Mylan, Sun Pharm Inds Inc, Westwood Squibb, Bristol Myers Squibb, and Encube, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for halcinonide. Four suppliers are listed for this compound.
Summary for HALCINONIDE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 6 |
NDAs: | 9 |
Drug Master File Entries: | 7 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Patent Applications: | 6,763 |
Drug Prices: | Drug price trends for HALCINONIDE |
What excipients (inactive ingredients) are in HALCINONIDE? | HALCINONIDE excipients list |
DailyMed Link: | HALCINONIDE at DailyMed |
Pharmacology for HALCINONIDE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for HALCINONIDE
Anatomical Therapeutic Chemical (ATC) Classes for HALCINONIDE
US Patents and Regulatory Information for HALCINONIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Westwood Squibb | HALOG | halcinonide | CREAM;TOPICAL | 017818-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Sun Pharm Inds Inc | HALOG-E | halcinonide | CREAM;TOPICAL | 018234-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Chartwell Rx | HALCINONIDE | halcinonide | CREAM;TOPICAL | 214723-001 | Sep 8, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
HALCINONIDE Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.